All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â![Nefcit Tablet_101159 Nefcit Tablet_101159](https://assets.mrmed.in/product-images/product-images-1708592590599-40840829-Nefcit%20Tablet_101159.jpg)
![Nefcit Tablet_101159 (2) Nefcit Tablet_101159 (2)](https://assets.mrmed.in/product-images/product-images-1719482843892-303885971-Nefcit%20Tablet_101159%20%282%29.jpg)
![Nefcit Tablet_101159 Nefcit Tablet_101159](https://assets.mrmed.in/product-images/product-images-1708592590599-40840829-Nefcit%20Tablet_101159.jpg)
Nefcit Tablet
Salt Composition : Ferric Citrate
Manufacturer : RINDZ PHARMA PVT LTD
Origin of Medicine : India
10 Tablet(s) In A Strip
Introduction to Nefcit Tablet
Nefcit tablet contains an active component as Ferric citrate. It is a medication used to treat iron deficiency anemia and hyperphosphatemia (increased phosphate levels in the body). It is a phosphate binder prescribed to manage hyperphosphatemia in chronic kidney patients undergoing dialysis. It is also an iron supplement that provides the elemental iron necessary to produce red blood cells. Iron is necessary for producing hemoglobin, a protein in red blood cells that carries oxygen throughout the body and is also an essential nutrient for overall energy production and metabolism. This medication is commonly prescribed when oral iron supplements alone are not sufficient or well-tolerated.
Inform your healthcare provider about any pre-existing medical conditions, such as gastrointestinal disorders, liver disease, kidney disease, or other health conditions. These may require special precautions or adjustments in the use of Nefcit tablets. Certain gastrointestinal disorders, such as ulcerative colitis, Crohn's disease, or other iron absorption conditions, may require special caution when using Nefcit tablets. The underlying condition should be managed and optimized before considering iron supplementation. If you have a known allergy or hypersensitivity to Nefcit tablet or other ingredients in the medication, you should avoid its use. This medication should not be used in individuals with iron overload conditions such as hemochromatosis, hemosiderosis, or other conditions that cause excessive iron accumulation in the body.Â
Uses of Nefcit Tablet
Nefcit tablet is used in the treatment of the following:
- Iron deficiency anemia
- Hyperphosphatemia
Therapeutic Effects of Nefcit Tablet
The therapeutic effect of Nefcit tablet is the replenishment of iron stores in the body, improving symptoms of iron deficiency anemia, increased energy levels, enhanced cognitive function, potential improvements in exercise performance, and specific benefits for individuals with chronic kidney disease. It helps address the underlying iron deficiency, promoting the production of red blood cells, oxygen transport, and overall well-being.
Interaction of Nefcit Tablet with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Nefcit tablet, reducing effectiveness by causing undesirable side effects.Â
More Information about Nefcit Tablet
- Store at room temperature, between 20°C to 25°C (68°F to 77°F).
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep away from children and pets.
How to consume Nefcit Tablet
Take the medication exactly as prescribed by your healthcare provider. The dosage and frequency will be determined based on your specific needs, the severity of your condition, and other factors. Nefcit tablet is typically taken orally with water. Follow the instructions on whether to take it with or without food.
Safety Advices for Nefcit Tablet
 Â
Pregnancy
 ÂLimited data regarding Nefcit tablet safety during pregnancy is available, so a healthcare professional should discuss and carefully evaluate its use during pregnancy.
 Â
Breast Feeding
 ÂThe safety of Nefcit tablet during breastfeeding is not well established, and it is recommended to exercise caution and consult with a healthcare professional before using this medication while breastfeeding.
 Â
Lungs
 ÂIf you have any pre-existing lung conditions, informing your healthcare provider about them before starting any new medication is important.
 Â
Liver
 ÂIf you have a pre-existing liver condition, such as liver disease, hepatitis, or cirrhosis, it is important to inform your healthcare provider. They will evaluate Nefcit tablet's potential risks and benefits in your specific case and may consider alternative treatment options if necessary.
 Â
Alcohol
 ÂDrinking alcohol can have various effects on the body, including interactions with medications and potential liver toxicity while taking Nefcit tablet.Â
 Â
Driving
 ÂIf you experience severe side effects, dizziness, drowsiness, or any other symptoms that could impair your alertness or coordination, it is advisable to refrain from driving until you have discussed your concerns with a healthcare professional and determined the best course of action.
Side Effects of Nefcit Tablet
Nefcit tablet cause some side effects like all medications, although not everyone will experience them.Â
Serious:
- Allergic reactions
- Skin rashes
Common:
- Dark stools
- Diarrhea, nausea, vomiting
- Constipation
- High potassium levels in the blood
- Abdominal pain
- Cough
Word of Advice
Advice regarding Nefcit tablet is to always consult with a healthcare professional before starting or making any changes to your medication regimen. They can assess your specific medical history, evaluate potential risks and benefits, provide personalized guidance, and monitor your progress throughout treatment. Additionally, closely follow the instructions and recommendations given by your healthcare provider, report any unusual or concerning symptoms promptly, and communicate openly about any concerns or questions you may have. Pregnant and breastfeeding individuals should consult with healthcare professionals before using this medication. Your healthcare professional is the best resource for ensuring safe and effective medication use.
FAQs
Q 1. Can Nefcit tablet be used in patients with kidney disease?
Nefcit tablet may require dose adjustments in individuals with severe renal impairment. The medication is primarily excreted through the kidneys, and reduced kidney function can affect its clearance from the body. It is important to consult with a healthcare professional who can assess your renal function and determine the appropriate dosage or alternative treatment options if needed.
Q 2. How long does it take for Nefcit tablet to work?
The timeframe for Nefcit tablet to show its effects can vary depending on the individual and the underlying condition being treated. It may take several weeks of consistent use to see improvement in iron levels and associated symptoms. It is important to continue taking this medication as prescribed and to follow up with your healthcare provider for monitoring and evaluation.
Q 3. Can Nefcit tablet cause stomach-related side effects?
Yes, gastrointestinal side effects such as nausea, vomiting, abdominal discomfort, and diarrhea can occur using Nefcit tablet. If these side effects are persistent or bothersome, consult your healthcare provider, who can guide managing these symptoms or adjust the dosage if necessary.
Q 4. What should I do if I miss a dose of Nefcit tablet?
If you miss a dose of Nefcit tablet, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not double up on doses to make up for a missed dose.
Q 5. Can Nefcit tablets be used in children?
The safety and effectiveness of Nefcit tablets in pediatric patients have not been established. Its use in children should be done under the guidance of a healthcare professional who can evaluate the specific circumstances and determine the most appropriate treatment options.
Fact Box of Nefcit Tablet
Molecule name: Ferric Citrate | Therapeutic class: Iron Supplements |
Pharmacological class: Iron Supplements
| Indications:Â 1. Iron deficiency anemia 2. Hyperphosphatemia |
References
- Akebia Therapeutics, Inc., US Food & Drug Administration, [Revised on Mar 2021] [Accessed on 13th July 2023], https://fda.report/DailyMed/AADD18E0-3752-11E4-8510-0800200C9A66.pdf
- Propak Health Ltd, European Medicine Agency, [Revised on Sept 2015] [Accessed on 13th July 2021],https://www.ema.europa.eu/en/documents/product-information/fexeric-epar-product-information_en.pdf
- J. Goddard, A.N. Turner, Kidney and Urinary Tract Disease, Davidson’s Principles and Practice of Medicine, 22nd Edition, 2014, 461-523.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.